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indices of health. Salivary HNP1-3 were determined before 
and after performing the first and last workout.
Results Salivary concentration and secretion rates of the 
HNP1-3 decreased in the beef condition only from pre-
first-workout (1.90 ± 0.83 μg/mL; 2.95 ± 2.83 μg/min, 
respectively) to pre-last-workout (0.92 ± 0.63 μg/mL, 
p = 0.025, d = 1.03; 0.76 ± 0.74 μg/min, p = 0.049, 
d = 0.95), and post-last-workout (0.95 ± 0.60 μg/mL, 
p = 0.032, d = 1.00; 0.59 ± 0.52 μg/min, p = 0.027, 
d = 1.02). No other significant differences between groups 
were observed.
Conclusions Supplementation with a carbohydrate–pro-
tein beverage may support resistance training outcomes in 
a comparable way as the ingestion of only carbohydrate. 
Furthermore, the ingestion of 20 g of hydrolyzed beef pro-
tein resulted in a decreased level and secretion rates of the 
HNP1-3 from baseline with no negative effect on blood 
indices of health.
Keywords Immune status · Strength performance · Body 
composition · Muscle thickness · Blood indices of health
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Abstract 
Purpose To examine the impact of ingesting hydrolyzed 
beef protein, whey protein, and carbohydrate on resistance 
training outcomes, body composition, muscle thickness, 
blood indices of health and salivary human neutrophil pep-
tides (HNP1-3), as reference of humoral immunity followed 
an 8-week resistance training program in college athletes.
Methods Twenty-seven recreationally physically active males 
and females (n = 9 per treatment) were randomly assigned 
to one of the three groups: hydrolyzed beef protein, whey 
protein, or non-protein isoenergetic carbohydrate. Treatment 
consisted of ingesting 20 g of supplement, mixed with orange 
juice, once a day immediately post-workout or before break-
fast on non-training days. Measurements were performed pre- 
and post-intervention on total load (kg) lifted at the first and 
last workout, body composition (via plethysmography) vastus 
medialis thickness (mm) (via ultrasonography), and blood 
Communicated by William J. Kraemer.
Electronic supplementary material The online version of this 
article (doi:10.1007/s00421-016-3520-x) contains supplementary 
material, which is available to authorized users.
 * Fernando Naclerio 
 f.j.naclerio@gre.ac.uk
1 Department of Life and Sports Sciences, University 
of Greenwich, Chatham Maritime, UK
2 Clinical Research Institute, Texas Tech University Health 
Sciences Center, Lubbock, TX, USA
3 Faculty of Science Engineering and Computing, Kingston 
University, London, UK
4 Exercise Science and Nutrition Laboratory, Texas A&M 
University, College Station, TX, USA
268 Eur J Appl Physiol (2017) 117:267–277
1 3
Introduction
Heavy exercise can lead to significant transient perturba-
tions in immune functions (Walsh et al. 2011b). In ath-
letes, the so-called immunosuppression has been associ-
ated with a weakened immune state lasting for up to 72 h 
after performing a strenuous exercise session (Nieman and 
Bishop 2006). Consequently, different nutritional strate-
gies, including the combination of carbohydrates with 
high-quality protein sources, ingested throughout the day 
(Jones et al. 2015) or during and after workouts or com-
petitions (Naclerio et al. 2015), have been proposed as an 
effective nutritional countermeasure to exercise-induced 
immune dysfunction with no detrimental effects on indices 
of health (e.g., blood chemistry measures) (Antonio et al. 
2016). Furthermore, adding protein to augment resistance 
training outcomes is supported by their capacity to rap-
idly increase amino acid availability to the working mus-
cles (Wilkinson et al. 2007). Specifically, the post-workout 
consumption of high-quality proteins would shift the bal-
ance in favor of muscle anabolism (Rennie et al. 2004) and, 
as a consequence, acts to maximize recovery and training 
effects between workouts (Morton et al. 2015).
Whey and beef protein extracts are high-quality pro-
tein sources with a similar amino acid composition to that 
found in the skeletal muscles (Chernoff 2004; Cruzat et al. 
2014). Either whey and beef protein sources include sulfur-
containing amino acids, such as cysteine and methionine or 
taurine that have been associated with an efficient immune 
status (Reidy and Rasmussen 2016). As a consequence, it 
could be possible to hypothesize that the ingestion of high-
quality protein extracts via the provision of an amino acid 
would support the immune response in individuals engaged 
in exhaustive and intense exercise programs.
Defensins, including alpha-defensins, are antimicro-
bial peptides (AMP) contributing to mucosal host defense 
providing a broad spectrum of antibacterial and antifungal 
activity (Wang 2014). The alpha-defensins also known as 
human neutrophil peptides (mainly HNP1-3) are predomi-
nantly found in neutrophils. Within the last 15 years, sev-
eral investigations have analyzed the response of these 
salivary markers of humoral immunology in various oral 
and systemic diseases (Yount and Yeaman 2012). Although 
some studies have investigated the impact of exercise on 
humoral immunity (Gleeson 2000), to the best of authors 
knowledge only two studies have analyzed the HNP1-3 
response to exercise (Davison et al. 2009; Gillum et al. 
2015) and neither of which have investigated the impact of 
combining nutritional supplements on the long-term adap-
tation of humoral immunity. Davison et al. (2009) reported 
an acute increase in the absolute concentration of the sali-
vary AMP (HNP1-3 and LL-37) in participants having 
performed a 2.5 h cycling intervention at 60% of VO2max 
while Gillum et al. (2015) observed an acute increase in 
the level of four AMP (LL-37, HNP1-3, LL-37, L Lacto-
ferrin, and Lysozyme) in participants after 45 min of run-
ning at 75% VO2peak. The post-exercise increase of salivary 
AMP may to some extent be related to an exercise-induced 
muscle inflammatory response (Davison et al. 2009). Extra-
neous dynamic exercise may induce airway inflammation 
and damage to airway epithelial cell (Davison et al. 2009). 
Thus, interventions aimed to analyze long-term adapta-
tion on the humoral immunity without side effects on the 
general health would be of relevant importance for ath-
letes. The aim of the current investigation was to compare 
the effectiveness of combining an 8-week resistance train-
ing program with a commercially available beef hydro-
lyzed protein powder product, whey isolate or a non-pro-
tein, carbohydrate only supplement on resistance training 
outcomes. The primary outcome for the study was sali-
vary alpha-defensins (HNP1-3) and secondary outcomes 
included performance, body composition, muscle thick-
ness, and various blood indices of health.
Methods
Participants
Forty-two recreationally active college participants (24 
male and 18 females) met the requirements to participate 
in this study. Key criteria for inclusion were: (a) 18–40 year 
of age, (b) regular recreationally training for at least 2 years 
with a minimum of 1 month performing resistance train-
ing, (c) free from musculoskeletal limitations, (d) agree 
not to ingest any other nutritional supplements or non-
prescription drugs or medication that might affect the 
immune system or muscle growth as well as the ability to 
train intensely during the study, and (e) fluent in English. 
Key criteria used for exclusion were: (a) history of various 
metabolic conditions and/or diseases; (b) use of a variety of 
medications, including but not limited to those with andro-
genic and/or anabolic effects and/or nutritional supple-
ments known to improve strength and/or muscle mass such 
as creatine, essential amino acid, whey protein, glutamine, 
dehydroepiandrosterone (DHEA) within 8 weeks prior to 
the beginning of the study; (d) current use of tobacco prod-
ucts; and/or in the case of female participants ingesting 
oral contraceptives; and (e) the presence of any orthopedic 
limitations or injuries. Compliance was confirmed verbally 
with participants upon arrival to the laboratory.
All participants were informed of the potential risks 
of the intervention before agreeing to comply with the 
intervention protocol and signed an informed consent. 
All experimental procedures were conducted in accord-
ance with the Declaration of Helsinki, and approved by 
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the University ethics committee. As summarized in Fig. 1, 
after assessing for eligibility, 27 of the 42 recruited par-
ticipants completed all aspects of the study. The study 
was conducted during the spring and summer of 2015 at 
the Centre for Science and Medicine in Sport and Exercise 
University of Greenwich Medway Campus, Kent (UK). 
Trial Registration: ClinicalTrials.gov, U.S. National Insti-
tutes of Health. (Identifier: NCT02425020) on 22nd April 
2015.
Experimental design
This study was a randomized controlled trial with three 
parallel groups, following a double blind between-partic-
ipant design. Participants were randomly allocated into 
three treatment groups: beef protein (n = 14); whey pro-
tein (n = 14) or carbohydrate only (CHO, n = 14). Before 
(test 1) and after (test 2) an 8-week intervention period, 
measurements of performance, body composition and mus-
cular thickness, total cholesterol, low density lipoprotein 
(LDL) and high density lipoprotein (HDL) cholesterol, 
triglycerides, glucose, urea, uric acid, creatine kinase (CK), 
creatinine, alanine transaminase (AST/GOT), aspartate 
transaminase (ALT/GPT) and HNP1-3 salivary immune-
peptides were assessed. Additionally, saliva was collected 
before and after the first and the last workout of the 8-week 
intervention protocol.
After inclusion and before the baseline assessment, par-
ticipants performed six sessions of familiarization, aimed 
to minimize any potential learning effects of the training 
procedures. Following the pre-intervention assessments, 
participants were matched by gender and resistance train-
ing background. Assignment of participants to treatments 
was performed by block randomization, using a block 
size of three, and in a double-blind fashion. Initial groups 
characteristics were as follows: beef: age 25.6 ± 5.7 years, 
height 1.72 ± 0.09 m, body mass 74.2 ± 17.3 kg; whey: 
age 25.9 ± 5.9 years, height 1.71 ± 0.10 m, body mass 
70.2 ± 11.3 kg; CHO: age 24.9 ± 8.1 years, height 
1.70 ± 0.09 m, body mass 70.4 ± 15.3 kg. No significant 
differences were observed between treatments at inclusion 
in sample characteristics.
Fig. 1  Flow diagram of partici-
pants throughout the course of 
the study
Assessed for eligibility (n=54) 
Excluded  (n=12) 
Not meeting inclusion criteria (n=10) 
Declined to participate (n=0) 
Other reasons (n=2) 
Analysed  (n= 9) 
Excluded from analysis (n=0)
Lost to follow-up (n=5) 
Discontinued intervention  (n=0) 
Allocated to Beef intervention          
(n= 14) 
Received allocated intervention 
(n= 9)
Did not receive allocated 
intervention (n=0)
Allocated to Whey intervention 
(n=14) 
Received allocated intervention 
(n=9)
Did not receive allocated 
intervention (n=0)
Randomized (n=42) 
Allocated to CHO group  
(n= 14) 
Received allocated intervention 
(n=9)
Did not receive allocated 
intervention (n=0)
Analysed  (n= 9) 
Excluded from analysis (n=0)
Analysed  (n= 9) 
Excluded from analysis (n=0)
Lost to follow-up (n=5) 
Discontinued intervention  (n=0) 
Lost to follow-up (n=5) 
Discontinued intervention  (n=0) 
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Dietary supplementation
The three products under study were presented as 20 g 
sachets of vanilla-flavored powder to be diluted in 250 mL 
of cold orange juice at each intake. The diluted drinks were 
similar in appearance, texture and taste and were isoener-
getic. The nutritional composition of each product and the 
amino acids profile of beef and whey proteins are shown in 
Table 1. Products were taken once a day for 8 weeks (56 
total doses per participant). On training days (resistance 
training or recreational exercise sessions), the supplement 
was ingested just after training, whereas on non-training 
days, the product was administered in the morning, before 
having breakfast.
Dietary (nutrition) monitoring
A research nutritionist collected dietary habits and 
explained the proper procedures for recording dietary 
intake. Each participant completed a 3-day food diary 
report (2 weekdays, and 1 weekend day). The food diary 
report was then analyzed using Dietplan 6 software to 
determine energy and macronutrient content. Participants 
were instructed to maintain their normal diet throughout 
the training period. To determine changes and evaluate 
differences caused by the supplementation protocol, diet 
composition was analyzed again during the last week of the 
intervention protocol.
Measurements
Body composition
Body mass (BM) and height were assessed, on a standard 
scale and stadiometer according the methods described by 
Ross and Marfel-Jones (1991).
Whole body densitometry was assessed using air dis-
placement via the Bod Pod® (Life Measurements, Concord, 
CA, USA) in accordance with the manufacturer’s instruc-
tions as detailed elsewhere (Dempster and Aitkens 1995). 
Briefly, the participants were tested wearing only tight fit-
ting clothing (swimsuit or undergarments) and an acrylic 
swim cap. Volunteers wore exactly the same clothing for all 
testing. Thoracic gas volume was estimated for all partici-
pants using a predictive equation integral to the Bod Pod® 
software. The calculated value for body density was used in 
the Siri equation (Siri 1961) to estimate the body composi-
tion. A complete body composition measurement was per-
formed twice. If the agreement on percentage of body fat 
was within 0.05%, the two tests were averaged. If the two 
tests were not within the 0.05% agreement, a third test was 
performed and, then, the average of the three completed tri-
als was used for all body composition variables.
Muscular thickness
Right-side vastus medialis muscle thicknesses were meas-
ured in real time using an Diasus diagnostic ultrasound 
imaging unit (Dynamic Imaging, Livingston, Scotland 
UK) coupled to a 50 mm probe at a frequency of 7.5 MHZ 
while participants were lying supine with arms and legs 
completely relaxed. The right lower limb was positioned 
with the knee extended. The probe was placed perpendicu-
lar to the skin surface and bone tissues at 80% of the dis-
tance between the lateral condyle of the femur and greater 
trochanter (Bradley and O’Donnell 2002). The probe was 
coated with a water-soluble transmission gel (Aquasonic 
100 Ultrasound Transmission gel) to provide acoustic con-
tact without depressing the dermal surface. Thickness was 
calculated as the distance between superficial and deep 
aponeuroses measured at the ends and middle region of 
each 3.8 cm-wide sonograph.
Three images of each muscle were obtained for each 
point and the average of the results was calculated. To 
favor reproducibility, probe placement was carefully noted 
for reproduction during the other test sessions and the 
Table 1  Nutritional composition of drinks per intake (20 g of powder 
plus 250 mL of orange juice)
EAA essential amino acids, CHO carbohydrates
Nutrient Beef Whey CHO
Energy value (kcal) 184 179 184
Carbohydrates (g) 25 25 45
Lipids (g) 1.54 0.3 0
Proteins (g) 16.4 18 0
Alanine (g) 1.04 1.06 –
Arginine (g) 1.06 0.38 –
Aspartic acid (g) 1.50 2.29 –
Cysteine (g) 0.16 0.48 –
Glutamic acid (g) 2.58 3.34 –
Glycine (g) 1.07 0.34 –
Histidine (g) 0.55 0.31 –
Isoleucine (g) 0.75 1.00 –
Leucine (g) 1.32 1.93 –
Lysine (g) 1.44 1.81 –
Methionine (g) 0.39 0.44 –
Phenylalanine (g) 0.65 0.61 –
Proline (g) 0.81 1.17 –
Serine (g) 0.65 1.05 –
Threonine (g) 0.73 1.44 –
Tryptophan (g) 0.19 0.39 –
Tyrosine (g) 0.52 5.57 –
Valine (g) 0.80 0.98 –
Total EAA (g) 6.82 8.91 –
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same operator performed all the measurements. To avoid 
any swelling in the muscles that could disturb the results, 
images were obtained at least 48 h before and after the pro-
gram intervention.
Training, performance evaluation and control of the 
intervention compliance
All participants followed the same resistance training rou-
tine, three times per week alternated with their habitual rec-
reational recreationally training (games or team sport ori-
ented activity) for a total of 8 weeks (24 resistance training 
workouts). During the 8 weeks of intervention, participants 
carried out their workout session late in the afternoon or 
early evening. After a warm up, the participants performed 
a total of three circuits involving one set of the following 
8 resistance exercises: (1) jump-squat (2) bench press, (3) 
parallel back squat, (4) upright row, (5) dumbbell alternate 
lunges, (6) shoulder press, (7) lateral hurdle jumps, and (8) 
abdominal crunch.
Every exercise included 12 maximum repetitions using 
the heaviest possible load (except the abdominal crunch 
that involved 20 repetitions per sets). A minimum rest was 
permitted in between exercises (only the time required to 
change from one exercise to the following). Recovery 
between circuits was 2–3 min. Resistance training sessions 
were completed in about 30 min. All training sessions were 
closely monitored to ensure effort, repetitions and inten-
sity established by experienced strength and conditioning 
coaches. All participants completed all lifts for each exer-
cise. The total load (kg) summarized all repetitions from 
the first six exercises was considered as the indicator of 
performance. Although lateral hurdle jumps and abdomi-
nals were performed with no external load, performing 
these exercises at the end of every circuit would impact 
on general fitness adaptation and the accumulated level of 
fatigue over the training session. The first and last workouts 
of the intervention period were used as evaluation sessions. 
The participants were instructed to refrain from any vigor-
ous activity for 48 h and avoid caffeine ingestion for at least 
48 h prior to both assessment sessions. As occurred during 
the entire training period, the first and last sessions were 
performed at the same time of the day for the same par-
ticipant. After completing the first session, each participant 
was given a batch of products, according to randomization.
Tolerance, collected from adverse events and compli-
ance with product intake (determined by an individual 
follow up of the participants), was evaluated continuously 
during the intervention. Only the participants who com-
pleted all the 24 training sessions were included in the final 
analysis.
Blood indices of health
Blood chemistry samples were taken before and after the 
8-week intervention period. Participants arrived at the 
physiology laboratory, after a fasting period of 6–8 h, on 
two separate occasions (1 day before and 1–2 days after 
completing the 8-week intervention period). Finger-prick 
capillary whole blood specimens were collected from each 
subject, under resting conditions, and analyzed using the 
Cholestech LDX Analyzer for fasting total cholesterol, 
HDL, LDL cholesterol triglycerides, and glucose, or the 
Reflotron Plus Clinical Chemistry Analyzer for CK, cre-
atinine, AST/GOT, ALT/GPT, urea and uric acid. Both 
devices were used according to the manufacturer’s instruc-
tions, using test strips (Reflotron Plus Clinical Chemistry 
Analyzer) or cassette (Cholestech LDX Analyzer).
Salivary alpha‑defensins HNP1‑3
Saliva collection
Saliva was collected at pre (before and after the first work-
out) and post (before and after the last workout) 8-week 
intervention period. At baseline or pre-workout, saliva sam-
ples were collected following the blood samples just a few 
minutes before starting the workout. For the post-workout 
sample, saliva was collected within 5 min after the exercise 
cessation.
Participants remained seated, performing minimal move-
ment for 10 min (pre-workout) or 5 min (post-workout) 
prior to each saliva collection. For all saliva samples, the 
mouth was rinsed with water at least 5 min before the col-
lection. The participant was requested to swallow to empty 
the mouth before each sample collection. Unstimulated 
whole saliva was collected by the spitting method while the 
participant remained seated, leaning forward and with the 
heads tilted down (Navazesh 1993). Saliva was collected 
for 1 min. To avoid circadian variation, saliva samples were 
collected in between 2 and 7 pm. The collected saliva was 
weighed to obtain precise flow rate (g/min) (Dawidson 
et al. 1996). The saliva was stored at −80 °C until further 
sample treatment and analysis.
Saliva analysis
Saliva samples were centrifuged (12,000g, 10 min; 4 °C) 
and the supernatant diluted 1000× with sample dilution 
buffer. Each sample was analyzed in duplicate with ELISA 
(Hycult biotech, The Netherlands) following the manu-
factures instructions. The calibration curve consisted of 
eight standards, ranging from 0.15 to 10 μg/mL HNP1-3. 
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Absorbance (450 nm) values for the saliva samples were 
interpolated from calibration standards with a 4-param-
eter logistic curve (My assays, version 2015). In addition, 
the alpha-defensins HNP1-3 secretion rates were deter-
mined by multiplying their concentration by the flow rate 
(mL min−1).
Statistical analysis
Sensitivity of the final sample size was calculated assum-
ing a model with three groups and four repeated meas-
ures, 0.05 α error probability, and 0.80 power (1 − β), to 
ensure adequacy of the study. A descriptive analysis was 
performed and subsequently the Kolmogorov–Smirnov 
and Shapiro–Wilk test were applied to assess normality. 
Sample characteristics at baseline were compared between 
conditions (beef vs. whey vs. CHO) using one-way anal-
ysis of variance (ANOVA). Change from pre to post in 
performance, body composition, muscle thickness, and 
blood indices was calculated by subtracting pre- from post-
values. Differences in change between conditions were 
assessed using one-way ANOVA. The changes in the con-
centration and secretion of HNP1-3 or the saliva flow rates 
were additionally analyzed using three conditions (beef vs. 
whey vs. CHO) × four times (pre-workout 1st vs. post-
workout 1st vs. pre-workout 24th vs. post-workout 24th) 
repeated measures ANCOVA, using pre-workout 1st as 
covariate. Bonferroni-adjusted post hoc analyses were per-
formed when appropriate. Generalized eta squared (η2
G
) and 
Cohen’s d values were reported to provide an estimate of 
standardized effect size (small d = 0.2, η2
G
 = 0.01; mod-
erate d = 0.5, η2
G
 = 0.06; and large d = 0.8, η2
G
 = 0.14). 
Significance level was set to p < 0.05. Results are reported 
as mean ± SD unless stated otherwise. Data analyses were 
performed with Stata 13.1 (StataCorp, College Station, TX, 
USA).
Results
Fifteen participants (9 male and 6 female) dropped from 
the study due to personal reasons, not related with the 
intervention protocol. Consequently, 27 participants, 15 
males and 12 females (5 (55.5%) and 4 (44.4%) per group, 
respectively) successfully completed the study. The sam-
ple was determined to be large enough to detect moderate 
group–time interactions (f = 0.26) through a power analy-
sis. The final composition of the three groups was equiva-
lent at baseline (Table 2).
Participants verbally confirmed that they maintained 
their diet throughout the trial period. Table 3 shows dietary 
monitoring results, presented as the average daily con-
sumption of carbohydrate, protein, fat (g kg−1 day−1), and 
energy (kcal kg−1 day−1), before and after intervention 
Table 2  Treatment groups 
description at baseline
All variables are presented as mean (standard deviation); F and p values were calculated using one-way 
analysis of variance with 2/24 degrees of freedom
Variable Beef (n = 9) Whey (n = 9) CHO (n = 9) F(2,24) p
Age (years) 25.6 ± 5.3 27.6 ± 5.2 24.4 ± 7.1 0.63 0.539
Height (m) 1.72 ± 0.09 1.73 ± 0.1 1.71 ± 0.08 0.14 0.872
Body mass (kg) 69.9 ± 14.35 70.27 ± 12.52 70.83 ± 10.43 0.01 0.988
Fat (%) 23.47 ± 11.53 18.87 ± 7.95 23.42 ± 11.65 0.57 0.574
Fat-free mass (%) 76.53 ± 11.53 81.13 ± 7.95 76.58 ± 11.65 0.57 0.574
Fat (kg) 18.54 ± 12.66 13.43 ± 6.9 16.89 ± 10.12 0.59 0.560
Fat-free mass (kg) 52.47 ± 7.43 56.85 ± 10.58 53.94 ± 10.23 0.49 0.618
Vastus Medialis thickness (mm) 28.24 ± 4.59 31.93 ± 3.09 30.04 ± 4.67 1.75 0.194
Total loaded (kg) 7403.4 ± 1746.5 7942.5 ± 1675.7 7215.6 ± 1637.8 0.45 0.643
Table 3  Analysis of the participant’s diet composition
* p < 0.05 significant difference from post- to pre-intervention
Treatment Beef Whey CHO
Pre Post Pre Post Pre Post
Proteins (g kg−1 day−1) 1.45 ± 0.66 1.70 ± 0.70* 1.47 ± 0.75 1.77 ± 0.92* 1.12 ± 0.56 1.12 ± 0.56
CHO (g kg−1 day−1) 3.39 ± 1.5 3.76 ± 1.59* 3.16 ± 2.23 3.55* (2.22) 2.59 ± 0.98 3.20 ± 1.04*
Fat (g kg−1 day−1) 1.20 ± 0.55 1.31 ± 0.56* 1.18 ± 0.40 1.18 ± 0.41 0.91 ± 0.12 0.91 ± 0.12
Energy (kcal kg−1 day−1) 30.99 ± 12.26 33.77 ± 12.41* 29.93 ± 13.50 31.8 ± 13.85* 23.71 ± 7.21 25.83 ± 7.11*
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for the three treatment groups. At baseline, no between-
group differences were observed for the amount of pro-
tein, carbohydrate, fat or energy intake. However, as a 
result of the nutritional intervention, all the three groups 
increased the intake of carbohydrate, while the beef and 
whey groups raised protein consumption but only beef 
increased fat intake. All the three treatment groups signifi-
cantly increased the total energy intake, with no difference 
between them.
Body composition, muscle thickness, performance 
and blood indices of health
Combining resistance training with any of the nutrition 
intervention (beef, whey or CHO) did not produce statis-
tically significant differences between the three treatment 
conditions in any of the analyzed variables (Table 4). 
However, beef showed large effect sizes for body mass 
(d = 1.27); total fat-free mass (d = 0.75) vastus medialis 
thickness (d = 1.93) and total kg lifted (d = 2.16); mean-
while, the CHO group showed large effect sizes for the 
total kg lifted (d = 1.73) and the vastus medialis thickness 
(d = 1.04) and so did the whey treatment only for the total 
kg lifted (whey d = 0.97).
Salivary alpha‑defensins HNP1‑3
After adjusting for pre-first-workout using ANCOVA, a 
significant supplement–time interaction effect for the con-
centration rates (F[6,72] = 2.47, p = 0.031, η2
G
 = 0.10), 
along with statistically significant effect of time 
(F[3,72] = 2.69, p = 0.053, η2
G
 = 0.05), but not differences 
between treatment conditions (F[2,23] = 0.65, p = 0.533, 
η
2
G
 = 0.014), was observed. No significant interaction 
(F(6,72) = 1.43, p = 0.215, η2
G
 = 0.07), treatment condi-
tion (F(2,23) = 0.54, p = 0.591, η2
G
 = 0.008) or time effect 
(F(3,72) = 2.01, p = 0.120, η2
G
 = 0.05) was determined on 
the secretion rates.
Bonferroni-adjusted post hoc contrasts to baseline 
revealed no statistically significant differences between 
groups at each time point for both the concentration and 
secretion rates. However, the beef treatment condition 
showed a statistically significant decrease of the base-
line concentration and secretion rates of HNP1-3 from 
the values measured before performing the first workout 
(1.90 ± 0.83 μg/mL; 2.95 ± 2.83 μg/min, respectively) 
of the values determined at post-intervention, before 
(0.92 ± 0.63 μg/mL, p = 0.025, d = 1.03; 0.76 ± 0.74 μg/
min, p = 0.049, d = 0.95), and after (0.95 ± 0.60 μg/
mL, p = 0.032, d = 1.00; 0.59 ± 0.52 μg/min, p = 0.027, 
d = 1.02) performing the last workout (Fig. 2a, b).
Saliva flow rate
No significant interaction (F[6,72] = 1.49, p = 0.193, 
η
2
G
 = 0.06) or treatment effect (F[2,24] = 0.47, p = 0.633, 
η
2
G
 = 0.01) was observed. However, a significant time 
effect (F[3,72] = 2.92, p = 0.040, η2
G
 = 0.06) was deter-
mined. Post hoc analysis revealed a significant intragroup 
decrease for the beef treatment condition in saliva flow rate 
Table 4  Differences observed 
in body composition, muscle 
thickness, performance and 
blood markers for the three 
treatment conditions after the 
8-week intervention period
All variables are presented as mean (standard deviation); F and p values were calculated using one-way 
analysis of variance with 2/24 degrees of freedom
Variable Beef (n = 9) Whey (n = 9) CHO (n = 9) F(2,24) p
Body weight (kg) 1.28 ± 1 0.26 ± 1.29 0.45 ± 1.59 1.53 0.236
Fat (%) 0.17 ± 1.35 −0.41 ± 2.08 −0.1 ± 0.44 0.36 0.705
Fat-free mass (%) −0.17 ± 1.35 0.41 ± 2.08 0.1 ± 0.44 0.36 0.705
Fat (kg) 0.47 ± 1.07 −0.33 ± 1.62 0.03 ± 0.77 0.99 0.385
Fat-free mass (kg) 0.88 ± 1.18 0.59 ± 0.86 0.42 ± 0.93 0.49 0.618
Vastus medialis thickness (mm) 3.13 ± 1.62 1.57 ± 3.28 1.7 ± 1.63 1.26 0.300
Total loaded (kg) 853.7 ± 395.2 479.1 ± 494.2 763.2 ± 442.3 1.73 0.198
Total cholesterol (mmol/L) 0.09 ± 0.29 0.06 ± 0.46 −0.26 ± 0.41 2.19 0.134
HDL cholesterol (mmol/L) 0 ± 0.35 0 ± 0.18 −0.11 ± 0.23 0.53 0.593
LDL cholesterol (mmol/L) 0 ± 0.52 0.03 ± 0.5 −0.22 ± 0.17 0.95 0.400
Triglycerides (mmol/L) 0.46 ± 0.98 0.17 ± 0.34 0.14 ± 0.72 0.51 0.608
Glucose (mmol/L) 0.48 ± 1.27 −0.14 ± 0.85 0.27 ± 0.93 0.84 0.445
Urea (mg/dL) 3.7 ± 9.7 2.71 ± 3.64 2.44 ± 7.58 0.07 0.931
Uric acid (mg/dL) −0.33 ± 0.87 −0.18 ± 2.01 0.18 ± 1.06 0.31 0.733
Creatinine (mg) 0.03 ± 0.23 −0.15 ± 0.17 0 ± 0.09 2.61 0.094
AST/GOT (U/L) −0.13 ± 4.1 1.52 ± 5.53 3.43 ± 7.57 0.82 0.451
ALT/GPT (U/L) −0.51 ± 2.57 −1.99 ± 8.12 −2.07 ± 9.25 0.13 0.877
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baseline levels from the first to the last training session 
at both pre- (1.336 ± 0.752 vs. 0.589 ± 0.398 mL/min, 
p = 0.036, d = 0.99) and post-workout (0.928 ± 0.286 vs. 
0.470 ± 0.280 mL/min, p = 0.009, d = 0.1.14) sessions. 
No significant differences were found between groups at 
any time point.
Discussion
Results suggest that consuming a post-workout carbohy-
drate–protein (beef or whey) beverage during an 8-week 
resistance training intervention promotes similar training 
and body composition outcomes than ingesting only carbo-
hydrate. The most relevant finding of the present investiga-
tion was the decrease of the baseline levels and secretion 
rates of the salivary alpha-defensins HNP1-3 determined 
after the 8-week intervention protocol in the beef treatment 
condition. A similar non-significant trend was observed for 
the whey protein group while no changes were reported for 
the participants ingesting only carbohydrates. None of the 
treatment conditions (beef, whey or CHO) affected the nor-
mal state of the biochemical blood indices of health or elic-
ited acute changes (pre- to post-workout before and after 
intervention) of the HNP1-3.
The increase of diet protein consumption in both beef 
and whey treatment group did not produce any nega-
tive effects on the analyzed blood markers of metabolism 
or hepatic function. The observed response is expected 
because the amount of daily protein intake for the both pro-
tein groups was always within the recommended range of 
~1–2 g kg−1 (Thomas et al. 2016), Table 3. Indeed, it has 
been recently indicated that consuming a high protein diet 
(2.6–3.3 g kg−1 day−1) over a 4-month period has no nega-
tive health-related effect on blood lipids or markers of renal 
and hepatic function in healthy resistance trained individu-
als (Antonio et al. 2016).
Data from the present investigation indicate that ingest-
ing a post-workout beverage containing protein with carbo-
hydrate or carbohydrate alone did not influence resistance 
training responses during the 8-week training period. Over-
all, the three treatment groups showed similar improve-
ments in body composition, muscle mass and the total kg 
lifted over the training intervention. However, the beef 
group seems to elicit a slightly superior body mass gain 
based on fat-free mass accretion. This appreciation would 
be supported by the largest effect size observed for the vas-
tus medialis thickness in beef (d = 1.93) compared to the 
other two treatment conditions (whey d = 0.48 and CHO 
d = 1.04). Even though previous studies have reported 
positive effects of canned, minced or beefsteak beef at 
promoting training outcomes in young (Negro et al. 2014) 
and elderly individuals (Symons et al. 2009), to the best 
of the authors’ knowledge, this is the first study to look at 
the effect of a hydrolyzed beef protein powder extract and 
compare its effects with those elicited using whey protein 
and a non-protein isoenergetic nutrient at supporting resist-
ance training outcomes along with analyses of its impact 
on health and immune markers in young athletes. The 
total energy provided in the three treatment conditions was 
almost similar or the amount of protein provided by beef 
and whey was not sufficient to elicit remarkable differences 
with respect to the contrast non-protein group. Neverthe-
less, the present results would still support the premise that 
daily caloric intake appears to be one of the most relevant 
factors affecting training adaptations during middle- to 
long-term exercise interventions (McLellan et al. 2014).
In contrast to previous studies (Davison et al. 2009; 
Gillum et al. 2015), we did not find acute increases of 
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Fig. 2  Acute and long-term changes in the concentration (a) and 
secretion rates (b) of the alpha-defensins HNP1-3 for the three treat-
ment conditions (mean ± 95% confidence intervals). Statistically sig-
nificant differences were only found from the baseline levels meas-
ured at pre- (before the first workout) to post-intervention, measured 
at both before and after the last workout for the beef treatment condi-
tion for both the concentration (p = 0.025 and p = 0.049) and secre-
tion rates (p = 0.032 and p = 0.027), respectively
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HNP1-3 after exercise at both before and after the trained 
intervention. Reasons for this discrepancy could be the 
nature of the physical exercise. Participants of the present 
investigation performed eight different resistance train-
ing exercises while previous studies have used submaxi-
mal cycling (Davison et al. 2009) or running (Gillum et al. 
2015) constant intensity protocol. Both aforementioned 
studies reported acute increases in the concentration of 
HNP1-3 determined immediately after exercise (Davison 
et al. 2009; Gillum et al. 2015) or until 1 h compared to 
pre-exercise values (Gillum et al. 2015). The post-exercise 
rise in the concentration and secretion rate of AMP could 
arise from the exercise-induced neutrophilia that occurs in 
mucosal secretions potentially due to airway inflammation 
or damage to the airway epithelial cells (Muns 1994). In 
addition, neutrophilia of the blood can increase HNP1-3 in 
saliva (Shiomi et al. 1993). These effects have been asso-
ciated with endurance cyclic exercises such as running or 
cycling but not with resistance type exercises. Neutrophils 
contain HNP1-3 in addition to other AMP, such as Lacto-
ferrin and Lysozyme (Gleeson 2007). Endurance continu-
ous exercise has been shown to activate neutrophils pos-
sibly causing the release of their contents into the saliva 
(Pyne 1994), and this is likely the cause of increased sali-
vary levels of AMP after exercise. Even though participants 
of the current investigation were instructed to perform 12 
repetitions of each exercise using the maximum possible 
amount of load and, consequently, all of them experienced 
maximum level of fatigue at the end of every session, no 
acute increase in the salivary concentration of HNP1-3 was 
determined for both at the beginning and at the end of the 
8-week intervention period. Perhaps, the different nature of 
the applied training protocol alternating exercises involving 
different muscle groups could have influenced the observed 
response.
It has been reported that an initial reduction in the con-
centration of some salivary AMP may be an adaptive 
response to exercise (West et al. 2010). However, the initial 
decrease would not be observed in previously well training 
athletes. Participants of the present investigation were rec-
reationally but regular resistance training individuals and 
only the participants included in the protein groups (beef 
and whey, respectively) showed a significant or a trend 
to decrease the levels of HNP1-3. The aforementioned 
response would reflect a reduced immune competence with 
a concomitant increase in the susceptibility to opportunis-
tic infection that has been reported in well-trained athletes 
(West et al. 2010). However, the clinical relevance of the 
above-mentioned modification is unknown, since the lev-
els of HNP1-3 measured for the three treatment conditions 
were similar to those obtained in previous studies (Davison 
et al. 2009; Kunz et al. 2015). In fact, the salivary levels of 
AMP including HNP1-3 can vary about 100-fold between 
individuals. It is, therefore, difficult to define normal-base-
line reference ranges (Gorr 2009). Nonetheless, when the 
individual responses are compared, it is worth noting that 
all participants but one in the beef group depicted a con-
sistent decrease in the levels of the HNP1-3 from pre- to 
post-intervention, whereas those in the whey and CHO 
condition showed different patterns of responses with 
three participants in the whey and two in the CHO treat-
ment group showing a reduced concentration of HNP1-3 
post-intervention.
The HNP1-3 entail a specific group of alpha-defensins 
that would increase in response to dental caries and the 
respiratory distress syndrome (Kunz et al. 2015). The after 
intervention decreased level of HNP1-3 observed in the beef 
and whey treatment groups could be related to the reduced 
concentration of carbohydrate ingested during the post-
workout period (0.36 ± 0.08 and 0.37 ± 0.06 g kg−1 for the 
beef and whey groups, respectively, vs. 0.65 ± 0.10 g kg−1 
for the CHO treatment condition). These results would sup-
port the notion that only carbohydrate ingestion with no 
added proteins would probably be the only effective nutri-
tional countermeasure to exercise-induced acute immune 
dysfunction (Walsh et al. 2011a). Nonetheless, the effec-
tiveness of ingesting carbohydrate at blunting the post-
exercises immunosuppression has been mainly observed 
in acute studies (Walsh et al. 2011a) where the decrease 
of different immunological markers including some sali-
vary defensins could be interpreted as a transient immune 
dysfunction with a concomitant higher risk of infection or 
virus attack (Davison et al. 2009). However, as the drop in 
the HNP1-3 level observed in the present study was not 
produced acutely but after an 8-week intervention, it can-
not be analyzed as a transient response but as an adaptive 
medium- to long-term adaptation similar to that observed 
in other salivary markers in well-trained athletes (West 
et al. 2010). Considering that HNP1-3 are a marker associ-
ated with exercise stress (Kunz et al. 2015), the lower level 
observed after the intervention in the beef group would be 
interpreted as a positive adaptive response that allows indi-
viduals to reduce the level of stress determined by a given 
exercise protocol. As previously mentioned, neutrophils are 
the most abundant white blood cell type and HNP1-3 are 
the most abundant antimicrobial peptide secreted by neu-
trophils. Thus, decreased levels of HNP1-3 have also been 
proposed as an index of reduced risk factor against virus 
and infection (Mehlotra et al. 2016).
The decreased levels of HNP1-3 resulted after the 
8-week intervention program, when participants achieved a 
better level of performance, which is in line with previous 
studies that have reported a lower concentration of salivary 
AMP, including HNP1-3 in better-fit athletes (Kunz et al. 
2015). Therefore, the reduced HNP1-3 levels observed 
after 8 weeks of training could be considered as a normal 
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adaptive response that might have been hasten by the inges-
tion of the beef protein beverage. Individual differences in 
training adaptation can be the reason by which some par-
ticipants allocated in the whey and CHO condition showed 
a similar post-intervention reduction in the HNP1-3 levels. 
Additionally, the lower average concentration of HNP1-3 
was also related to an increased salivary flow rate observed 
only for the beef treatment condition. However, differently 
from the study of Kunz et al., no differences in perfor-
mance were observed between the three conditions (beef, 
whey, and CHO) compared to the present study. The higher 
salivary flow rate, observed in the beef group, may act as 
a compensatory mechanism to maintain adequate rates of 
salivary AMP secretion and may, in fact, be indicative of 
greater parasympathetic nervous system activity (resulting 
in a large amount of diluted saliva) and vagal tone under 
the similar training stimulus (Chicharro et al. 1998; Coote 
2010) for this particular group.
It is worthy to note that the large variability in the con-
centration of HNP1-3 observed at rest and in response to 
exercise observed in the current study is in accordance 
with others (Davison et al. 2009) who have recognized 
the variance as a source of limitation for the detection of 
intervention-induced changes in mucosal parameters, par-
ticularly in a parallel group design (Jones et al. 2015). 
Given the importance of mucosal immune parameters 
toward host defense (West et al. 2010), further investigation 
of the effects of post-workout feeding strategies on other 
salivary AMP (e.g., salivary Lactoferrin and Lysozyme) is 
warranted.
In conclusion, the present investigation suggests that the 
ingestion of a carbohydrate–protein (beef or whey) post-
workout beverage may support some possible adaptations 
induced by resistance training in a comparable way as the 
ingestion of only carbohydrate. Furthermore, the ingestion 
of 20 g of protein powder, mainly from hydrolyzed beef 
protein, would also promote an early decrease of the aver-
age baseline levels and secretion rates of the salivary alpha-
defensins (HNP1-3) with no negative effect on the blood 
indices of health in recreationally trained college athletes.
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